UK - GlaxoSmithKline's £900m ($1.5bn) buy-in deal last year would not have been possible without transition managers, said Martin Mannion, director of pensions finance, investments and risk.
GSK entered into a buy-in deal with Prudential in November of last year. (Global Pensions; 16 November 2010) Speaking at a recent transition management debate hosted by Global Pensions, Mannion ...
To continue reading this article...
Join Professional Pensions
- Unlimited access to real-time news, analysis and opinion from the industry
- Receive our in-depth monthly magazine in either print or digital format
- Access our Sustainable Investment Hub covering news and opinion from thought leaders in the ESG space
- Receive important and breaking news stories selected by the Editors in our daily newsletter
- Hear from industry experts and other forward-thinking leaders
- Receive a monthly members-only newsletter with exclusive opinion pieces from leading industry experts and a feature from the magazine in advance of its release date